Does Brimonidine Interact with Monoamine Oxidase Inhibitors Maois?
CDI records a moderate classification for Brimonidine and Monoamine Oxidase Inhibitors Maois. The stored summary is: MAO inhibitors may interfere with brimonidine metabolism, potentially resulting in increased systemic side effects such as hypotension. The mechanism involves interference with metabolism and uptake of circulating amines. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Interference with metabolism and uptake of circulating amines
What To Tell Your Doctor or Pharmacist
If you are taking Brimonidine and your doctor is considering prescribing Monoamine Oxidase Inhibitors Maois (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider